Vidalta is licensed for the treatment of hyperthyroidism which is a common hormonal disease of middle aged to older cats. Vidalta tablets are prolonged release allowing for once daily dosing. Vidalta tablets contain the active carbimazole which is a metabolic prodrug that is rapidly and almost entirely converted to methimazole in vivo. Methimazole concentrates in the thyroid glands where it blocks the activity of the enzyme thyroid peroxidise and thereby regulates the production of thyroid hormones in a dose dependent manner.
The absorption of methimazole when administered as Vidalta prolonged release tablets is delayed compared to conventional release tablets. The concentration/time profile is flatter ensuring there is no pronounced methimazole peaks.
For uses, dosage, contra-indications and warnings please consult product leaflet. Further information is available on request. Use medicines responsibly.
Tubs containing 30 tablets.